Get the Stockscreener App
15.89
2.85%
0.44
After Hours:
15.89
Bausch Lomb Corp stock is traded at $15.89, with a volume of 244.44K.
It is up +2.85% in the last 24 hours and up +2.38% over the past month.
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
See More
Previous Close:
$15.45
Open:
$15.46
24h Volume:
244.44K
Relative Volume:
0.48
Market Cap:
$5.63B
Revenue:
$4.89B
Net Income/Loss:
$-263.00M
P/E Ratio:
-20.55
EPS:
-0.7734
Net Cash Flow:
$-167.84M
1W Performance:
+5.23%
1M Performance:
+2.38%
6M Performance:
+40.74%
1Y Performance:
-19.22%
1-Day Range:
$15.46
$15.98
1-Week Range:
$14.44
$15.98
52-Week Range:
$10.45
$20.71
Bausch Lomb Corp Stock (BLCO) Company Profile
Name
Bausch Lomb Corp
Sector
Industry
Phone
908-541-5456
Address
520 APPLEWOOD CRESCENT, VAUGHAN
Compare BLCO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BLCO
Bausch Lomb Corp
|
15.89 | 5.47B | 4.89B | -263.00M | -167.84M | -0.7734 |
|
ISRG
Intuitive Surgical Inc
|
578.87 | 201.52B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
195.49 | 54.73B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
ALC
Alcon Inc
|
79.66 | 37.45B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
255.80 | 36.57B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
280.84 | 19.71B | 2.96B | 487.70M | 344.00M | 6.6758 |
Bausch Lomb Corp Stock (BLCO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-01-25 | Initiated | Goldman | Neutral |
| May-02-25 | Reiterated | H.C. Wainwright | Buy |
| Mar-28-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-11-24 | Downgrade | Citigroup | Buy → Neutral |
| Dec-02-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-15-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Jul-10-24 | Initiated | Raymond James | Outperform |
| May-06-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jan-04-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-12-23 | Initiated | Stifel | Hold |
| Oct-03-23 | Resumed | Evercore ISI | Outperform |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Mar-09-23 | Initiated | Needham | Hold |
| Dec-21-22 | Initiated | Barclays | Equal Weight |
| Sep-12-22 | Initiated | H.C. Wainwright | Buy |
| Jul-26-22 | Initiated | RBC Capital Mkts | Outperform |
| Jun-24-22 | Initiated | Evercore ISI | Outperform |
| Jun-06-22 | Initiated | Citigroup | Buy |
| May-31-22 | Initiated | Deutsche Bank | Hold |
| May-31-22 | Initiated | Goldman | Neutral |
| May-31-22 | Initiated | Guggenheim | Buy |
| May-31-22 | Initiated | JP Morgan | Neutral |
| May-31-22 | Initiated | Jefferies | Buy |
| May-31-22 | Initiated | Morgan Stanley | Equal-Weight |
| May-31-22 | Initiated | Wells Fargo | Overweight |
| May-11-22 | Initiated | Cowen | Outperform |
View All
Bausch Lomb Corp Stock (BLCO) Latest News
Long Term Trading Analysis for (BLCO) (BLCO:CA) - news.stocktradersdaily.com
Citigroup Downgrades Bausch + Lomb (BLCO) - MSN
How Bausch + Lomb Corporation (S2L) stock responds to bond market2025 Market Outlook & Weekly Top Gainers Alerts - newser.com
Is Bausch + Lomb Corporation stock a buy for dividend growthJuly 2025 Levels & Real-Time Chart Breakout Alerts - newser.com
Is Bausch + Lomb Corporation (S2L) stock worth buying before Fed actionMarket Movement Recap & Consistent Profit Trading Strategies - newser.com
How big funds are accumulating Bausch + Lomb Corporation (S2L) stockJuly 2025 Intraday Action & AI Enhanced Execution Alerts - newser.com
Trading (BLCO) With Integrated Risk Controls (BLCO:CA) - news.stocktradersdaily.com
Activist Investor Drops Scathing Letter, Slams Cooper's 'Growth At All Costs' Approach - Benzinga
Will Bausch + Lomb Corporation stock benefit from commodity supercycleJuly 2025 Big Picture & Real-Time Chart Breakout Alerts - newser.com
Will Bausch + Lomb Corporation stock announce special dividend2025 Fundamental Recap & AI Based Buy and Sell Signals - newser.com
Why global investors buy Bausch + Lomb Corporation stockEntry Point & Weekly Breakout Opportunity Watchlist - newser.com
Does Bausch + Lomb Corporation (S2L) stock trade below intrinsic valueWeekly Market Summary & Expert Approved Momentum Ideas - newser.com
Bausch + Lomb to Engage at Citi Global Healthcare Conference - The Globe and Mail
Real time breakdown of Bausch + Lomb Corporation stock performancePortfolio Risk Report & Weekly Consistent Profit Watchlists - newser.com
Can Bausch + Lomb Corporation (S2L) stock sustain double digit ROEJuly 2025 Action & Risk Controlled Stock Alerts - newser.com
Is Bausch + Lomb Corporation stock dividend growth reliableJuly 2025 Rallies & Long-Term Investment Growth Plans - newser.com
What margin trends mean for Bausch + Lomb Corporation stockQuarterly Portfolio Report & Target Return Focused Picks - newser.com
What consensus target says about Bausch + Lomb Corporation (S2L) stock2025 Major Catalysts & Entry Point Confirmation Signals - newser.com
[Form 4] Bausch & Lomb Corp Insider Trading Activity - Stock Titan
Bausch + Lomb to Participate in Citi Global Healthcare Conference - MarketScreener
Bausch + Lomb (NYSE: BLCO) leaders to speak at 2025 Citi Global Healthcare Conference - Stock Titan
Bausch + Lomb Corporation (BLCO) Stock Forecasts - Yahoo! Finance Canada
Bausch + Lomb’s Rochester site positioned as key hub for next-gen contact lens production - Rochester Business Journal
Short interest data insights for Bausch + Lomb Corporation2025 Key Lessons & Weekly Top Gainers Trade List - newser.com
How strong is Bausch + Lomb Corporation stock revenue growthEarnings Recap Report & AI Driven Stock Price Forecasts - newser.com
Can Bausch + Lomb Corporation stock resist sector downturns2025 Market Trends & Community Supported Trade Ideas - newser.com
Bausch Lomb Corp Stock (BLCO) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):